# Dexycu

NDC: 71879-001
Generic name: dexamethasone
Labeler / Manufacturer: EyePoint Pharmaceuticals US, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SUSPENSION
Routes: INTRAOCULAR
Marketing started: 20180522

FDA application: NDA208912

## Active ingredients

- DEXAMETHASONE: 517 ug/.005mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71879-001"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71879-001
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=583d70ed-bc42-465b-983d-c770db58406f